US 12,083,139 B2
Use of IGF-2 receptor agonist ligands for treatment of Angelman Syndrome and autism
Cristina Maria Alberini, New York, NY (US); Dirk Trauner, New York, NY (US); and Christopher James Arp, The Woodlands, TX (US)
Assigned to New York University, New York, NY (US)
Appl. No. 17/267,715
Filed by New York University, New York, NY (US)
PCT Filed Aug. 12, 2019, PCT No. PCT/US2019/046227
§ 371(c)(1), (2) Date Feb. 10, 2021,
PCT Pub. No. WO2020/033971, PCT Pub. Date Feb. 13, 2020.
Claims priority of provisional application 62/717,372, filed on Aug. 10, 2018.
Prior Publication US 2021/0315914 A1, Oct. 14, 2021
Int. Cl. A61K 31/7024 (2006.01); A61K 38/30 (2006.01); A61P 25/00 (2006.01)
CPC A61K 31/7024 (2013.01) [A61K 38/30 (2013.01); A61P 25/00 (2018.01)] 4 Claims
 
1. A compound that has the structure:

OG Complex Work Unit Chemistry